Solid dispersion of lumefantrine using soluplus® by solvent evaporation method: formulation, characterization and in-vitro antimalarial screening (Record no. 17606)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | a |
003 - CONTROL NUMBER IDENTIFIER | |
control field | OSt |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20220922151121.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 220922b xxu||||| |||| 00| 0 eng d |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | AIKTC-KRRC |
Transcribing agency | AIKTC-KRRC |
100 ## - MAIN ENTRY--PERSONAL NAME | |
9 (RLIN) | 18043 |
Author | Kanojiya, Pranita Sunil |
245 ## - TITLE STATEMENT | |
Title | Solid dispersion of lumefantrine using soluplus® by solvent evaporation method: formulation, characterization and in-vitro antimalarial screening |
250 ## - EDITION STATEMENT | |
Volume, Issue number | Vol.56(1), Jan-Mar |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Place of publication, distribution, etc. | karnataka |
Name of publisher, distributor, etc. | Association of Pharmaceutical Teachers of India (APTI) |
Year | 2022 |
300 ## - PHYSICAL DESCRIPTION | |
Pagination | 121-132p. |
520 ## - SUMMARY, ETC. | |
Summary, etc. | Objectives: Lumefantrine (LUM) is an antimalarial drug having poor aqueous solubility. The objective was to formulate the solid dispersion of LUM and improve the solubility and dissolution rate. Materials and Methods: Solvent evaporation technique was used to prepare solid dispersions (SDs) with Soluplus® (SOL) using a rotary evaporator. The feasibility of the formation of SD for LUM and SOL was assessed by the Hansen solubility parameter. The drug solubility was analyzed by the HPLC method and the ratio of LUM: SOL was optimized to 1:2. The SD was characterized by DSC, FTIR, XRD and SEM. Results: The results showed that the LUM and SOL had groups that lead to the interaction between them and this led to conversion from crystalline to amorphous form and thus improved the dissolution rate. The solubility of L2 was found to be 135 ± 3.3 μg/mL using the selected dissolution media (0.1 N HCl+1% Myrj 52). The in-vitro antimalarial screening was performed using the P. falciparum 3D7 strain and the in-vitro cytotoxicity test was performed using the Vero cell line. The higher antimalarial efficacy of L2 SD was observed as compared to plain LUM. The selectivity index value of LUM SD depicted its non-toxicity. Stability study was carried out for three months and the SDs were evaluated for the drug content, change in weight and in-vitro drug release. No significant changes were observed after three months in the drug content, SD weight and in-vitro drug release. Thus the L2 SD was found to be stable. Conclusion: The prepared SD improved the solubility as well as the dissolution rate of the drug. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
9 (RLIN) | 4774 |
Topical term or geographic name entry element | PHARMACOLOGY |
700 ## - ADDED ENTRY--PERSONAL NAME | |
9 (RLIN) | 16877 |
Co-Author | Charde, Yogita |
773 0# - HOST ITEM ENTRY | |
Place, publisher, and date of publication | Bengluru Association of Pharmaceutical Teachers of India (APTI) |
International Standard Serial Number | 0019-5464 |
Title | Indian journal of pharmaceutical education and research |
856 ## - ELECTRONIC LOCATION AND ACCESS | |
URL | https://www.ijper.org/sites/default/files/IndJPhaEdRes-56-1-121.pdf |
Link text | Click here |
942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
Source of classification or shelving scheme | |
Koha item type | Articles Abstract Database |
Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Permanent Location | Current Location | Shelving location | Date acquired | Barcode | Date last seen | Price effective from | Koha item type |
---|---|---|---|---|---|---|---|---|---|---|---|---|
School of Pharmacy | School of Pharmacy | Archieval Section | 2022-09-22 | 2022-1707 | 2022-09-22 | 2022-09-22 | Articles Abstract Database |